NCT06329661 - A Clinical Trial to Evaluate the Corneal Endothelial Health of DED Subjects Treated With Cyclosporine | Biotech Hunter

Enrollment

204

Participants

Timeline

Start Date

April 22, 2024

Primary Completion Date

July 30, 2025

Study Completion Date

July 30, 2025

Conditions

Dry Eye Disease

Interventions

DRUG

Cyclosporine ophthalmic solution, 0.1%

Colorless and clear opthalmic solution containing 0.1% Cyclosporine

DRUG

Saline solution, 0.6%

Colorless and clear sodium chloride solution (0.6%)

Trial Locations (6)

CYS-007 Investigational Site, Cranberry Township

CYS-007 Investigational Site, Garner

CYS-007 Investigational Site, Shelby

CYS-007 Investigational Site, Memphis

CYS-007 Investigational Site, Torrance

CYS-007 Investigational Site, Newport Beach